Showing results (551-560 of 592) with videos related to

Sort By:
Pageof 60
International Journal of Radiation Oncology, Biology, Physics|December 25, 2018
Three-Fraction Intracavitary Accelerated Partial Breast Brachytherapy: Early Provider and Patient-Reported Outcomes of a Novel RegimenKrishan R Jethwa, Sean S Park, Karthik Gonuguntla, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|August 7, 2001
The parkin gene and its phenotype. Italian PD Genetics Study Group, French PD Genetics Study Group and the European Consortium on Genetic Susceptibility in Parkinson's DiseaseV Bonifati, G De Michele, C B Lücking, et al.
Annals of Neurology|August 26, 1998
The alpha-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: a study of 230 European cases. European Consortium on Genetic Susceptibility in Parkinson's DiseaseJ Vaughan, A Durr, J Tassin, et al.
Neurology|August 23, 2000
Association of an interleukin 1 alpha polymorphism with Alzheimer's diseaseY Du, R C Dodel, B J Eastwood, et al.
European Journal of Neurology|December 10, 2013
Genetic assessment of familial and early-onset Parkinson's disease in a Greek populationM Bozi, D Papadimitriou, R Antonellou, et al.
European Journal of Neurology|March 20, 2010
EFNS guidelines on the molecular diagnosis of channelopathies, epilepsies, migraine, stroke, and dementiasJ-M Burgunder, J Finsterer, Z Szolnoki, et al.
The Journal of Biological Chemistry|November 20, 1997
CVT-313, a specific and potent inhibitor of CDK2 that prevents neointimal proliferationE E Brooks, N S Gray, A Joly, et al.
Journal of Medicinal Chemistry|September 17, 2004
Novel cyclooxygenase-1 inhibitors discovered using affinity fingerprintsNancy Hsu, Danying Cai, Komath Damodaran, et al.
European Journal of Neurology|May 28, 2009
EFNS guidelines on the molecular diagnosis of neurogenetic disorders: general issues, Huntington's disease, Parkinson's disease and dystoniasH F Harbo, J Finsterer, J Baets, et al.
American Journal of Human Genetics|February 17, 2001
Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effectsM Periquet, C Lücking, J Vaughan, et al.
Pageof 60